InsiderClue
Stocks · Health care · Pharmaceutical Preparations

MBX Biosciences, Inc.

MBX Clue Score39
United States Fiscal year ends December CIK 0001776111
$53.24 -0.02% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $53.24 +235.69% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 13 Sep 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2023Operating income−35.3Net income−32.6EPS, diluted−31.96Fiscal year 2024Operating income−68.2Net income−61.9EPS, diluted−5.82Fiscal year 2025Operating income−98.1Net income−87.0EPS, diluted−2.38
FY2023FY2024FY2025
Operating income −35.3 −68.2 −98.1
Net income −32.6 −61.9 −87.0
Growth
EPS, diluted −31.96 −5.82 −2.38

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−32.0Capital expenditure−0.1Free cash flow−32.1Fiscal year 2024Operating cash flow−54.7Capital expenditure−0.9Free cash flow−55.6Fiscal year 2025Operating cash flow−79.9Capital expenditure−1.9Free cash flow−81.9
FY2023FY2024FY2025
Operating cash flow −32.0 −54.7 −79.9
Capital expenditure −0.1 −0.9 −1.9
Free cash flow −32.1 −55.6 −81.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash30.5Shareholders’ equity−72.5Fiscal year 2024Cash49.4Shareholders’ equity257.4Fiscal year 2025Cash75.3Shareholders’ equity369.2
FY2023FY2024FY2025
Cash 30.5 49.4 75.3
Shareholders’ equity −72.5 257.4 369.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −24.1% −23.6%
−38.7% −23.1% −22.6%
Balance and payout
5.1% 4.1% 4.1%